What's on this Page
What is Terconazole
Terconazole is a triazole antifungal agent available for intravaginal use. It is structurally related to imidazole-derivative antifungal agents, although imidazoles have 2 nitrogens in the azole ring while terconazole and other triazoles have 3 nitrogens in the azole ring.
Terconazole is usually fungicidal against Candida albicans.
Although antifungal activity has been demonstrated against other fungi, it is indicated only for the treatment of vulvovaginal candidiasis. Terconazole was approved by the FDA in 1987.
Brand Names
- Terazol 3
- Terazol 7
- Zazole
Indications
- Candida albicans
- Candida sp.
- vulvovaginal candidiasis
Monitoring Parameters
- laboratory monitoring not necessary
Contraindications
- breast-feeding
- children
- contraceptive devices
- infants
- menstruation
- neonates
- ocular exposure
- ophthalmic administration
- pregnancy
Side Effects
- abdominal pain
- anaphylactoid reactions
- arthralgia
- asthenia
- bronchospasm
- chills
- dizziness
- dysmenorrhea
- fever
- headache
- malaise
- myalgia
- nausea
- photosensitivity
- pruritus
- rash
- teratogenesis
- toxic epidermal necrolysis
- urticaria
- vaginal irritation
- vaginal pain
- vomiting
Interactions
There are no drug interactions associated with Terconazole products.